Ligand Pharmaceuticals Announces Licensing Agreements with MEI Pharma, Sage Therapeutics & Merck Unit

Represented Ligand Pharmaceuticals (Nasdaq: LGND) in out-licensing and partnering agreements with MEI Pharma, Inc. (Nasdaq: MEIP); Viking Therapeutics, Inc.; Sage Therapeutics, Inc.; and a unit of Merck Serono International S.A.